Anil K Agarwal, Abhishek Yadav, C. P., Paromita Kuity, Jaya Mishra
Anil K Agarwal1, Abhishek Yadav2, C. P.2, Paromita Kuity2*, Jaya Mishra2
1Professor, Department of Community Medicine, G R Medical College, Gwalior, MP 474009.
2PG (MD) Std – Department of Community Medicine, G R Medical College, Gwalior, MP 474009.
Volume - 12,
Issue - 4,
Year - 2022
Aim/Objective: The primary objective of this review is to describe the Evolution of current allopathic Anti-malarial Pharmacotherapy and understanding significance of Antimalarial drugs in Malaria Program/Public Health Program in India. Subject/Method: Review of Research Literature and Context-Content-Outcome Analysis of Antimalarial Drug Policy. Findings: Antimalarial drug list expanded extensively and the drug dose intensity is proportional to disease transmission in region/area; both the factors medicalizing the community significantly. The conceptual understanding of malaria remains within biomedicine domain evidenced by the fact that much of importance (over-reliance) given to least effective individual level technical interventions like drugs that too; without considering immunity and nutritional status of both individual and community. Indian Planners seems confused to differentiate (or ignoring) between Malaria’s behavior at Individual level and community level. Thus, the Malaria planning lacks ethical consideration for resource allocation in Public Health Planning evidenced by the fact that large resources allocated to least effective intervention that serves the profit making purpose of private sector pharma industry. Sufferings of the most impoverished household of community remain unaddressed in Health planning. Policy for Antimalarial Pharmacotherapy is unable to serve its primary purpose of relieving suffering of community, prevention of mortalities, reducing morbidities, slowing down the resistance, and reducing drug load in community. Conclusion: The investment in medications to tackle malaria as Public Health problem looks costly investments as it consumes heavy resources and its benefits/success claim is questionable. There is mismatch in planning and field reality as intervention in the form of drugs does not match the requirement as per epidemiological complexity. Health Planning is comprehensive exercise for any country. Ignoring voices from field/frontline workers prove detrimental for health planning. Every organization or individual involved in health planning would be having different opinions as per their interest but the final decision regarding resource allocation should consider the field reality following good public health ethics.
Cite this article:
Anil K Agarwal, Abhishek Yadav, C. P., Paromita Kuity, Jaya Mishra. Development of Antimalarial Pharmacotherapy and its importance in Malaria Treatment/Public Health Program. Asian Journal of Pharmaceutical Analysis. 2022; 12(4):233-2. doi: 10.52711/2231-5675.2022.00038
Anil K Agarwal, Abhishek Yadav, C. P., Paromita Kuity, Jaya Mishra. Development of Antimalarial Pharmacotherapy and its importance in Malaria Treatment/Public Health Program. Asian Journal of Pharmaceutical Analysis. 2022; 12(4):233-2. doi: 10.52711/2231-5675.2022.00038 Available on: https://ajpaonline.com/AbstractView.aspx?PID=2022-12-4-3
1. Anvikar, A. R., Arora, U., Sonal, G. S., Mishra, N., Shahi, B., Savargaonkar, D. Valecha, N. (2014). Antimalarial drug policy in India: Past, present and future. The Indian Journal of Medical Research, 139(2), 205–215.
2. Baird, J. K., M. F. Sustriayu Nalim, H. Basri, S. Masbar, B. Leksana, E. Tjitra, R. M. Dewi, M. Khairani, and F. S. Wignall. (1996). Survey of resistance to chloroquine by Plasmodium vivax in Indonesia. Trans. R. Soc. Trop. Med. Hyg. 90:409-411.
3. Banerji, D. (1985). Health and Family Planning Services in India: An epidemiological, socioculturaland political analysis and a perspective. New Delhi:
4. Bose, A. (2004). Malaria Deaths in Rajasthan Desert. Economic and Political Weekly, 39(25), 2557–2559. Retrieved from http://www.jstor.org/stable/4415164
5. Chowdhry, A. (2010). Defeat malaria. New Delhi: Health Harmony.
6. Coatney, G. R. 1963. Pitfalls in a discovery: the chronicle of chloroquine. Am. J. Trop. Med. Hyg. 12:121-128.
7. Das, A., Anvikar, A. R., Cator, L. J., Dhiman, R. C., Eapen, A., Mishra, N., … Valecha, N. (2012). Malaria in India: The center for the study of complex malaria in India. Acta Tropica, 121(3), 267–273. https://doi.org/10.1016/j.actatropica.2011.11.008
8. Dowdle, W. R. (1998). The principles of disease elimination and eradication. Bulletin of the World Health Organization, 76 Suppl 2, 22–25.
9. Gupta, G. P. (2013). Indian national science academy sponsored report on new anti-malarial drug discovery in india and future strategy for malaria control.
10. Kumar, A., Valecha, N., Jain, T., and Dash, A. P. (2007). Burden of malaria in India: Retrospective and prospective view. The American Journal of Tropical Medicine and Hygiene, 77(6 Suppl), 69–78.
11. M.C. Purohit, Anuj Kandwal, Reena Purohit, A.R. Semwal, Shama Parveen, Arun K. Khajuria. Antimicrobial Activity of Synthesized Zinc Oxide Nanoparticles using Ajuga bracteosa Leaf Extract. Asian Journal of Pharmaceutical Analysis. 2021; 11(4):275-0.
12. Muraleedharan, V. R. (2005). Maladies, preventives, and curatives: Debates in public health in India chapter on Cinchona Policy in British India by V.R. Muraleedharan (A. K. Bagchi and K. Soman, Eds.). New Delhi: Tulika Books.
13. Neiva, A. 1910. Ueber die Bildung einur chininresistenten Rasse des Malaria parasite. Mem. Inst. Oswaldo Cruz 2:131-140. [Google Scholar]
14. Narain, J., and Nath, L. (2018). Eliminating malaria in India by 2027: The countdown begins! Indian Journal of Medical Research, 148(2), 123. https://doi.org/10.4103/ijmr.IJMR_1175_18
15. Narasimham, M. V. V. L. (1988). National Malaria Eradication Program (pp. 9–44). New Delhi: NIHFW.
16. Pattanayak, S., Sharma, V. P., Kalra, N. L., Orlov, V. S., and Sharma, R. S. (1994). Malaria paradigms in India and control strategies. Indian Journal of Malariology, 31(4), 141–199.
17. PETERS, W. (1973). Antimalarial Drugs and their actions. Postgraduate Medical Journal, (49), 573–583.
18. Priya, R., Gaitonde, R., Gandhi, M. P., Sarkar, A., Das, S., and Ghodajkar, P. (2019). The Alma Ata Declaration and Elements for a PHC 2.0. Medico Friend Circle Bulletin, 380, 1–8. Retrieved from http://www.mfcindia.org/mfcpdfs/MFC380.pdf
19. Qadeer, I. (1988). Health services system in India: An expression of socioeconomic inequalities. The Great Concern, (1), 3–8, 12.
20. Ramachandra Rao, T. (1974). Report of the Consultative Experts to determine alternative strategies under NMEP. New Delhi: GOI.
21. Rentmeester, C. A., and Dasgupta, R. (2012). Good epidemiology, good ethics: Empirical and ethical dimensions of global public health. Indian Journal of Medical Ethics, (4). https://doi.org/10.20529/IJME.2012.081
22. Seema R Nikam, Amol SJagdale, Sahebrao S Boraste, Shrikant B Patil. Bioanalysis – Method Development, Validation, Sample Preparation, its Detection Techniues and its Application. Asian Journal of Pharmaceutical Analysis. 2021;; 114).27-5. doi: 10.52711/2231—5675.2021.00051. Available on https:/ajpaonline.com/AbstractView.aspx? PID=2021-11-4-9]
23. Sharma, V. P. (1999). Current scenario of malaria in India. Parassitologia, 41(1–3), 349–353.
24. Sharma, V. P. (2012). Battling malaria iceberg incorporating strategic reforms in achieving Millennium Development Goals and malaria elimination in India. The Indian Journal of Medical Research, 136(6), 907–925.
25. Singh, G. P., Chitkara, S., Kalra, N. L., Makepur, K. B., and Narasimham, M. V. (1990). Development of a methodology for malariogenic stratification as a tool for malaria control. The Journal of Communicable Diseases, 22(1), 1–11.
26. Thompson, P. E., and L. M. Werbel. 1972. Antimalarial agents: chemistry and pharmacology. In G. deStevens (ed.), Medicinal chemistry. Academic Press, Inc., New York, N.Y.
27. White, N. J. (2002). The assessment of antimalarial drug efficacy. Trends in Parasitology, 18(10), 458–464. https://doi.org/10.1016/S1471-4922(02)02373-5
28. WHO. (2015). Guidelines for the treatment of malaria.
29. WHO. (2018). World malaria report 2018.
30. WHO Model Prescribing Information “Drugs used in Parasitic Diseases.” (1995). WHO Geneva.
31. World Health Organization. (1976). Regional Advisory Committee on Medical Research, Second Session, South East Asia Region (pp. 1–23). New Delhi.
32. Yadav, R. S., and Ghosh, S. K. (2002). Radical Curative Efficacy of Five-Day Regimen of Primaquine for Treatment of Plasmodium vivax Malaria in India. Journal of Parasitology, 88(5), 1042–1044. https://doi.org/10.1645/0022-3395(2002)088[1042:RCEOFD]2.0.CO;2